Literature DB >> 12955722

Spectrum of FANCA mutations in Italian Fanconi anemia patients: identification of six novel alleles and phenotypic characterization of the S858R variant.

Maria Savino1, Adriana Borriello, Maria D'Apolito, Maria Criscuolo, Maria Del Vecchio, Anna Monica Bianco, Michele Di Perna, Rita Calzone, Bruno Nobili, Adriana Zatterale, Leopoldo Zelante, Hans Joenje, Fulvio Della Ragione, Anna Savoia.   

Abstract

Fanconi anemia (FA) is an autosomal recessive disorder characterized by genomic instability, bone marrow failure, congenital malformations, and cancer predisposition. FA is a genetically heterogeneous disease with at least seven genes so far identified. The role of FA proteins is unknown although they interact in a common functional pathway. Here, we report six novel FANCA sequence changes and review all the mutations identified in Italy. Except for two missense substitutions, all are expected to cause a premature termination of the FANCA protein at various sites throughout the molecule. The premature terminations are due to nonsense and splice site mutations, as well as small insertions and deletions, and large genomic rearrangements. The expected truncated proteins were not detectable on Western blot analyses. The FANCA-S858R variant is instead expressed at lower level than that seen in normal cell lines and is associated with a non-ubiquinated FANCD2 protein, strongly suggesting that the amino acid substitution is a disease-causing mutation. The spectrum of FA mutations is widely in agreement with the heterogeneous ethnic origin of the Italian population. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955722     DOI: 10.1002/humu.9180

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  10 in total

1.  Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.

Authors:  Maria Castella; Roser Pujol; Elsa Callén; Juan P Trujillo; José A Casado; Hans Gille; Francis P Lach; Arleen D Auerbach; Detlev Schindler; Javier Benítez; Beatriz Porto; Teresa Ferro; Arturo Muñoz; Julián Sevilla; Luis Madero; Elena Cela; Cristina Beléndez; Cristina Díaz de Heredia; Teresa Olivé; José Sánchez de Toledo; Isabel Badell; Montserrat Torrent; Jesús Estella; Angeles Dasí; Antonia Rodríguez-Villa; Pedro Gómez; José Barbot; María Tapia; Antonio Molinés; Angela Figuera; Juan A Bueren; Jordi Surrallés
Journal:  Blood       Date:  2011-01-27       Impact factor: 22.113

2.  Mutations in Fanconi anemia genes and the risk of esophageal cancer.

Authors:  Mohammad R Akbari; Reza Malekzadeh; Pierre Lepage; David Roquis; Ali R Sadjadi; Karim Aghcheli; Abbas Yazdanbod; Ramin Shakeri; Jafar Bashiri; Masoud Sotoudeh; Akram Pourshams; Parviz Ghadirian; Steven A Narod
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

3.  FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required for functional integrity of the FA-BRCA DNA repair pathway.

Authors:  Abdullah Mahmood Ali; Arun Pradhan; Thiyam Ramsingh Singh; Changhu Du; Jie Li; Kebola Wahengbam; Elke Grassman; Arleen D Auerbach; Qishen Pang; Amom Ruhikanta Meetei
Journal:  Blood       Date:  2012-02-17       Impact factor: 22.113

4.  RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway.

Authors:  Jenny Xie; Hyungjin Kim; Lisa A Moreau; Shannon Puhalla; Judy Garber; Muthana Al Abo; Shunichi Takeda; Alan D D'Andrea
Journal:  J Clin Invest       Date:  2015-03-09       Impact factor: 14.808

5.  Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population.

Authors:  Nadhir Litim; Yvan Labrie; Sylvie Desjardins; Geneviève Ouellette; Karine Plourde; Pascal Belleau; Francine Durocher
Journal:  Mol Oncol       Date:  2012-09-11       Impact factor: 6.603

6.  Hypersensitivity to chemoradiation in FANCA carrier with cervical carcinoma-A case report and review of the literature.

Authors:  Igor Sirák; Zuzana Šinkorová; Mária Šenkeříková; Jiří Špaček; Jan Laco; Hana Vošmiková; Stanislav John; Jiří Petera
Journal:  Rep Pract Oncol Radiother       Date:  2014-12-05

7.  Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation.

Authors:  L Grodecká; T Kováčová; M Kramárek; S Seneca; K Stouffs; C De Laet; F Majer; T Kršjaková; P Hujová; K Hrnčířová; P Souček; W Lissens; E Buratti; Tomas Freiberger
Journal:  J Mol Med (Berl)       Date:  2016-11-12       Impact factor: 4.599

8.  Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology.

Authors:  Daniela De Rocco; Roberta Bottega; Enrico Cappelli; Simona Cavani; Maria Criscuolo; Elena Nicchia; Fabio Corsolini; Chiara Greco; Adriana Borriello; Johanna Svahn; Marta Pillon; Cristina Mecucci; Gabriella Casazza; Federico Verzegnassi; Chiara Cugno; Anna Locasciulli; Piero Farruggia; Daniela Longoni; Ugo Ramenghi; Walter Barberi; Fabio Tucci; Silverio Perrotta; Paola Grammatico; Helmut Hanenberg; Fulvio Della Ragione; Carlo Dufour; Anna Savoia
Journal:  Haematologica       Date:  2014-02-28       Impact factor: 9.941

9.  Hypomorphic FANCA mutations correlate with mild mitochondrial and clinical phenotype in Fanconi anemia.

Authors:  Roberta Bottega; Elena Nicchia; Enrico Cappelli; Silvia Ravera; Daniela De Rocco; Michela Faleschini; Fabio Corsolini; Filomena Pierri; Michaela Calvillo; Giovanna Russo; Gabriella Casazza; Ugo Ramenghi; Piero Farruggia; Carlo Dufour; Anna Savoia
Journal:  Haematologica       Date:  2017-12-21       Impact factor: 9.941

10.  A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia.

Authors:  Charles Lu; Peter Riedell; Christopher A Miller; Ian S Hagemann; Peter Westervelt; Bradley A Ozenberger; Michelle O'Laughlin; Vincent Magrini; Ryan T Demeter; Eric J Duncavage; Malachi Griffith; Obi L Griffith; Lukas D Wartman
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.